VDU:CA:TSX-Vanguard FTSE Developed All Cap Ex US (CAD)

ETF | International Equity |

Last Closing

CAD 44.42

Change

-0.08 (-0.18)%

Market Cap

CAD 0.44B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for International Equity

Symbol Name Price(Change) Market Cap
XEF:CA iShares Core MSCI EAFE IMI

-0.08 (-0.21%)

CAD 8.98B
ZEA:CA BMO MSCI EAFE

-0.01 (-0.04%)

CAD 8.66B
XFH:CA iShares Core MSCI EAFE IMI Ind..

+0.13 (+0.40%)

CAD 1.48B
XIN:CA iShares MSCI EAFE (CAD Hedged)

+0.13 (+0.34%)

CAD 1.39B
QDX:CA Mackenzie International Equity..

N/A

CAD 1.00B
ZDM:CA BMO MSCI EAFE (CAD Hedged)

+0.03 (+0.10%)

CAD 0.89B
VEF:CA Vanguard FTSE Developed All Ca..

+0.18 (+0.32%)

CAD 0.64B
FCIQ:CA Fidelity International High Qu..

-0.07 (-0.18%)

CAD 0.60B
HXDM:CA Global X Intl Developed Market..

-0.18 (-0.37%)

CAD 0.58B
ZDI:CA BMO International Dividend Uni..

-0.02 (-0.08%)

CAD 0.46B

ETFs Containing VDU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (International Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.38% 49% F 51% F
Dividend Return 1.50% 21% F 38% F
Total Return 12.88% 49% F 51% F
Trailing 12 Months  
Capital Gain 21.27% 80% B- 55% F
Dividend Return 2.46% 38% F 42% F
Total Return 23.72% 69% C- 54% F
Trailing 5 Years  
Capital Gain 31.15% 50% F 57% F
Dividend Return 10.81% 52% F 45% F
Total Return 41.96% 59% D- 57% F
Average Annual (5 Year Horizon)  
Capital Gain 5.98% N/A N/A 58% F
Dividend Return 8.04% N/A N/A 60% D-
Total Return 2.05% N/A N/A 57% F
Risk Return Profile  
Volatility (Standard Deviation) 13.17% N/A N/A 77% C+
Risk Adjusted Return 61.00% N/A N/A 77% C+
Market Capitalization 0.44B 63% D 58% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike